Pure Global

Hemopatch Sealing Hemostat - Collagen haemostatic agent - ARTG 477685

Access comprehensive regulatory information for Hemopatch Sealing Hemostat - Collagen haemostatic agent in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 477685 and sponsored by Baxter Healthcare Pty Ltd, manufactured by Baxter Healthcare SA in Switzerland. The device registration started on February 04, 2025.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class III
ARTG 477685
Class III
Hemopatch Sealing Hemostat - Collagen haemostatic agent
ARTG ID: 477685
Good Name: Baxter Healthcare Pty Ltd - Hemopatch Sealing Hemostat - Collagen haemostatic agent
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

HEMOPATCH is indicated as a haemostatic device and surgical sealant for procedures in which control of bleeding or leakage of other body fluids by conventional surgical techniques is either ineffective or impractical.

Device Classification
Risk Class
Class III
Product Type
Single Device Product
ARTG Category
General
Registration Information
ARTG ID
477685
Start Date
February 04, 2025
Effective Date
February 04, 2025
Manufacturer
Country
Switzerland
Address
Thurgauerstrasse 130, Glattpark, Opfikon, 8152